Advent International, a leading private equity firm, acquired Industria Chimica Emiliana, a leading producer of UDCA, an active pharmaceutical ingredient, from Bartoli Family. Financial terms were not disclosed. Advent, the Bartoli family and ICE’s management team will work closely together to further strengthen the company’s support functions and capabilities, and aid its customers in reaching more patients by developing new pipeline products to treat additional indications. "UDCA is key to helping millions of people around the world fight diseases. We’re delighted to have Advent on board as we enter our next phase of growth,” Enzo Bartoli, ICE Chairman.